ArticleHepatobiliary surgery and nutrition2023

Conversion therapy for advanced cholangiocarcinoma in the era of molecular targeted therapy and immune therapy.

Zunyi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.